Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome

References

• Aydin S (2011). Effects of Cardiopulmonary Bypass on Expression of Apelin and Salusin and Investigation of whether or not they are Locally Synthesized in the Aorta, Saphenous Vein and Artery Graft. Specialization Thesis in Medicine, Dicle University, Diyarbakir, Turkey.
   Google Scholar
• Aydin S, Eren MN, Aydin S, Ozercan IH, Dagli AF (2012). The bioactive peptides salusins and apelin-36 are produced in human arterial and venous tissues and the changes of their levels during cardiopulmonary bypass. Peptides 37: 233–239.
   PubMed Web of Science ®Google Scholar
• Aydin S, Eren MN, Aydin S (2013). Physiology and clinical role of salusin-α and β peptides in the cardiovascular system. Turkiye Klinikleri J. Cardiovasc. Sci. In press.
   Google Scholar
• Bruce KD, Byrne CD (2009). The metabolic syndrome: common origins of a multifactorial disorder. Postgrad. Med. J. 85: 614–621.
   PubMed Web of Science ®Google Scholar
• Citil C (2012). Metabolik Sendrom Oluşturulmuş Ratların Karaciğer, Beyin ve Serumlarında Salusin Ekspresyonlarının Araştırılması. PhD thesis, Firat University, Elazig, Turkey.
   Google Scholar
• Czernichow S, Greenfield JR, Galan P, Jellouli F, Safar ME, Blacher J, Hercberg S, Levy BI (2010). Macrovascular and microvascular dysfunction in the metabolic syndrome. Hypertens. Res. 33: 293–297.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486–2497.
   PubMed Web of Science ®Google Scholar
• Gonçalves JP, Oliveira A, Severo M, Santos AC, Lopes C (2012). Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 41: 450–457.
   PubMed Web of Science ®Google Scholar
• Hsu SM, Raine L, Fanger H (1981). Use of avidin- biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577–580.
   PubMed Web of Science ®Google Scholar
• Kojima M, Kangawa K (2005). Ghrelin: structure and function. Physiol. Rev. 85: 495–522.
   PubMed Web of Science ®Google Scholar
• Levesque J, Lamarche B (2008). The metabolic syndrome: definitions, prevalence and management. J. Nutrigenet. Nutrigenom. 1: 100–108.
   PubMedGoogle Scholar
• Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, Grande JP, Textor SC, Lerman A, Lerman LO (2011). Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am. J. Physiol. Renal Physiol. 301: F1078–F1087.
   Web of Science ®Google Scholar
• Lu W, Song K, Wang Y, Zhang Q, Li W, Jiao H, Wang G, Huang G (2012). Relationship between serum uric acid and metabolic syndrome: an analysis by structural equation modeling. J. Clin. Lipidol. 6: 159–167.
   PubMed Web of Science ®Google Scholar
• Marquezine GF, Oliveira CM, Pereira AC, Krieger JE, Mill JG (2008). Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction. Int. J. Cardiol. 129: 259–265.
   PubMed Web of Science ®Google Scholar
• Mulè G, Cottone S, Mongiovì R, Cusimano P, Mezzatesta G, Seddio G, Volpe V, Nardi E, Andronico G, Piazza G, Cerasola G (2006). Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr. Metab. Cardiovasc. Dis. 16: 54–59.
   PubMed Web of Science ®Google Scholar
• Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T (2010). Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice. Atherosclerosis 212: 70–77.
   PubMed Web of Science ®Google Scholar
• Sahin I, Aydin S (2013). Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose. Biotech. & Histochem. 88: 153–160.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lozada LG, Tapia E, Jimenez A, Bautista P, Cristobal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M (2007). Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am. J. Physiol. Renal Physiol. 292: 423–429.
   PubMed Web of Science ®Google Scholar
• Sato K, Koyama T, Shichiri M (2011). Physicochemical characteristics of salusin-beta and establishment of the radioimmunoassay. Rinsho Byori. 59: 121–127.
   PubMedGoogle Scholar
• Takenoya F, Hori T, Kageyama H, Funahashi H, Takeuchi M, Kitamura Y, Shichiri M, Shioda S (2005). Co-existence of salusin and vasopressin in the rat hypothalamo-hypophyseal system. Neurosci. Lett. 385: 110–113.
   PubMed Web of Science ®Google Scholar
• Ti Y, Wang F, Wang ZH, Wang XL, Zhang W, Zhang Y, Bu PL (2012). Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension. J. Hum. Hypertens. 26: 603–609.
   PubMed Web of Science ®Google Scholar
• Vrbikova J, Hainer V (2009). Obesity and polycystic ovary syndrome. Obes. Facts 2: 26–35.
   PubMed Web of Science ®Google Scholar
• Wang G, Li Q, Niu T, Chen C, Xu X (2002). Association of GYS1 and beta(3)-AR gene with postprandial hyperglycemia and serum uric acid in type 2 diabetes mellitus. Chin. Med. J. (Engl.) 115: 1308–1311.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Y, Shan S, Hu T, Chen H, Tian J, Ren A, Zhou X, Yuan W, Lin L (2012). Salusins protect myocardium against ischemic injury by alleviating endoplasmic reticulum stress. Sci. China Life Sci. 55: 358–366.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, Sakai T, Sato K, Hongo S, Nose K, Ota H, Kobayashi Y, Katagiri T, Shichiri M, Miyazaki A (2008). Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117: 638–648.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T, Shichiri M (2011). The roles of salusins in atherosclerosis and related cardiovascular diseases. J. Am. Soc. Hypertens. 5: 359–365.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Sato K, Itoh F, Wakabayashi K, Shichiri M, Hirano T (2012). Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease. Sensors (Basel) 12: 4974–4985.
   PubMed Web of Science ®Google Scholar
• Wong ND (2007). Metabolic syndrome: cardiovascular risk assessment and management. Am. J. Cardiovasc. Drugs 7: 259–272.
   PubMed Web of Science ®Google Scholar
• Yu F, Zhao J, Yang J, Gen B, Wang S, Feng X, Tang C, Chang L (2004). Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul. Pept. 122: 191–197.
   PubMedGoogle Scholar
• Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E (2012). Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care 35: 99–104.
   PubMed Web of Science ®Google Scholar